Medium materiality6/10
Anixa Biosciences price target lowered to $6 from $7 at H.C. Wainwright
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright lowers ANIX target to $6 from $7. Current price is $2.71. Price change since signal: -0.55. Target remains well above current price, implying upside opportunity.
- Target 6 vs price 2.71; upside potential despite downgrade
Key facts
- 01
Target: $6
- 02
Posted price: $2.71
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Yi Chen
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.